AU1649700A - Novel formulation - Google Patents
Novel formulationInfo
- Publication number
- AU1649700A AU1649700A AU16497/00A AU1649700A AU1649700A AU 1649700 A AU1649700 A AU 1649700A AU 16497/00 A AU16497/00 A AU 16497/00A AU 1649700 A AU1649700 A AU 1649700A AU 1649700 A AU1649700 A AU 1649700A
- Authority
- AU
- Australia
- Prior art keywords
- novel formulation
- formulation
- novel
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000009472 formulation Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Emergency Medicine (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Endocrinology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Medicinal Preparation (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA199801703 | 1998-12-22 | ||
| DKPA199801703 | 1998-12-22 | ||
| PCT/DK1999/000699 WO2000037081A1 (en) | 1998-12-22 | 1999-12-14 | Novel formulation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU1649700A true AU1649700A (en) | 2000-07-12 |
Family
ID=8107354
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU16497/00A Abandoned AU1649700A (en) | 1998-12-22 | 1999-12-14 | Novel formulation |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP1140084A1 (en) |
| JP (1) | JP2002532551A (en) |
| AU (1) | AU1649700A (en) |
| WO (1) | WO2000037081A1 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6723340B2 (en) * | 2001-10-25 | 2004-04-20 | Depomed, Inc. | Optimal polymer mixtures for gastric retentive tablets |
| MY152185A (en) * | 2005-06-10 | 2014-08-29 | Novartis Ag | Modified release 1-[(3-hydroxy-adamant-1-ylamino)-acetyl]-pyrrolidine-2(s)-carbonitrile formulation |
| CN114533699B (en) * | 2021-12-15 | 2023-05-26 | 南通联亚药业股份有限公司 | Cyclobenzaprine hydrochloride sustained-release capsule and preparation method thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4680323A (en) * | 1983-12-01 | 1987-07-14 | Hans Lowey | Method and composition for the preparation of controlled long-acting pharmaceuticals for oral administration |
| MY113463A (en) * | 1994-01-04 | 2002-03-30 | Novo Nordisk As | Novel heterocyclic compounds |
| WO1997022338A1 (en) * | 1995-12-15 | 1997-06-26 | Novo Nordisk A/S | Novel method |
| US5783212A (en) * | 1996-02-02 | 1998-07-21 | Temple University--of the Commonwealth System of Higher Education | Controlled release drug delivery system |
-
1999
- 1999-12-14 EP EP99959252A patent/EP1140084A1/en not_active Withdrawn
- 1999-12-14 JP JP2000589192A patent/JP2002532551A/en active Pending
- 1999-12-14 AU AU16497/00A patent/AU1649700A/en not_active Abandoned
- 1999-12-14 WO PCT/DK1999/000699 patent/WO2000037081A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2000037081A1 (en) | 2000-06-29 |
| EP1140084A1 (en) | 2001-10-10 |
| JP2002532551A (en) | 2002-10-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU3485999A (en) | Neo-tryptophan | |
| AU2623899A (en) | Novel thiobenzamides | |
| AUPP650198A0 (en) | Cement formulation | |
| AU2350199A (en) | Novel aminoorganofunctionalsiloxanes | |
| AU5575398A (en) | Hairdye compositions | |
| AU3437799A (en) | City-car | |
| AU3522399A (en) | Carvedilol-galenics | |
| AU4037699A (en) | Novel aryl-hydro naphthalenal kanamines | |
| AU3253699A (en) | Myxochelines | |
| AU5378599A (en) | Oral formulation | |
| AU2724799A (en) | Novel endo-xylogalacturonase | |
| AU6217199A (en) | Compositions | |
| GB9810180D0 (en) | Novel formulation | |
| AU3204999A (en) | Futureball | |
| AU2609599A (en) | Sensor-coupling | |
| AU2069199A (en) | Codelets | |
| AU1649700A (en) | Novel formulation | |
| AUPP053197A0 (en) | Compositions | |
| AU1055399A (en) | Rollerboard | |
| AU2648899A (en) | Composition | |
| AU1137300A (en) | Cement formulation | |
| AU3347599A (en) | Aeromobile | |
| AU9347498A (en) | Imidazotriazolopyrimidines | |
| AU2840799A (en) | 1-phosphanorbornadienes | |
| AU1779099A (en) | Heterocyclyl-derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |